Empagliflozin may not exhibit clinical or mortality benefit in COVID-19 patients Written By Jacinthlyn Sylvia5 Dec 2023 10:15 AM ISTThe RECOVERY trial has concluded that empagliflozin, a drug proposed for its anti-inflammatory and metabolic effects, does not provide substantial...
Vitamin D supplementation may not prevent bone fractures in children: Study Written By Dr. Kamal Kant Kohli4 Dec 2023 10:00 AM ISTResearchers at Queen Mary University of London and the Harvard T.H. Chan School of Public Health have found in a major clinical trial that vitamin D...
Type 2 diabetes diagnosis at age 30 can reduce life expectancy by up to 14 years Dr. Kamal Kant Kohli5 Oct 2023 8:00 PM ISTAn individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an international team of...
Diabetes diagnosis at age 30 may cut life expectancy by up to 14 years Written By Isra Zaman5 Oct 2023 9:15 AM ISTAn individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, warns an international team...
Kids with type 1 diabetes with residual C peptide encounter lower complications: Lancet Written By Medha Baranwal21 Jun 2023 11:15 AM ISTFinland: A longitudinal analysis revealed that children with type 1 diabetes rapidly progressed to insulin deficiency. Still, many adults and...
Insulin Degludec non-inferior to detemir in pregnant women with T1D Written By Aditi27 April 2023 8:15 AM ISTResearchers have interpreted that among pregnant women with a history of type 1 diabetes, degludec is non-inferior to detemir.This article entitled...
Weekly BIF as efficacious as degludec with lower incident hypoglycaemia in type 2 diabetes patients: Lancet Written By Medha Baranwal14 Feb 2023 11:15 AM ISTUSA: Weekly basal insulin Fc (BIF) provided similar efficacy to degludec despite higher fasting glucose targets in the BIF groups, according to...
Is dyslipidemia a potential post-acute sequela of SARS-CoV-2 infection? Written By Medha Baranwal17 Jan 2023 3:00 AM ISTUSA: A recent study published in The Lancet Diabetes & Endocrinology adds to growing evidence that COVID-19 survivors may be at higher risk for...
Tirzepatide, potential new treatment for inadequately controlled type 2 diabetes patients: Lancet Written By Medha Baranwal8 Aug 2022 12:00 PM ISTJapan: New research shows tirzepatide to be a potential new treatment option for type 2 diabetes that is not controlled well with a single oral...
Islet autoantibodies screening at age 2 and 6 years predicts type 1 diabetes onset: Lancet Written By Medha Baranwal26 July 2022 10:15 AM ISTUSA: Initial screening for islet autoantibodies at 2 years and 6 years is sensitive and efficient for predicting the onset of type 1 diabetes in later...
COVID-19 vaccine protects people of all body weights from hospitalization and death Written By Isra Zaman2 July 2022 9:30 AM ISTCOVID-19 vaccines greatly reduced the number of cases of severe COVID-19 disease for everyone regardless of their body size, according to a new study...
Tirzepatide bests insulin degludec for achieving blood sugar targets in type 2 diabetes: Lancet Written By Medha Baranwal29 April 2022 9:00 AM ISTUSA: Once-weekly treatment with tirzepatide compared to insulin degludec led to superior glycemic control in patients with type 2 diabetes (T2D) on...
